Oral Administration of Semicarbazide Limits Weight Gain together with Inhibition of Fat Deposition and of Primary Amine Oxidase Activity in Adipose Tissue.

Oral Administration of Semicarbazide Limits Weight Gain together with Inhibition of Fat Deposition and of Primary Amine Oxidase Activity in Adipose Tissue.

Item
http://www.wikidata.org/entity/Q34572256
Inactivation of Semicarbazide-Sensitive Amine Oxidase Stabilizes the Established Atherosclerotic Lesions via Inducing the Phenotypic Switch of Smooth Muscle CellsVascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosisHoming-associated molecules CD73 and VAP-1 as targets to prevent harmful inflammations and cancer spread.Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects.The amine oxidase inhibitor phenelzine limits lipogenesis in adipocytes without inhibiting insulin action on glucose uptake.Anatomical distribution of primary amine oxidase activity in four adipose depots and plasma of severely obese women with or without a dysmetabolic profile.Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.Metabolic Effects of Oral Phenelzine Treatment on High-Sucrose-Drinking Mice
P2860

Oral Administration of Semicarbazide Limits Weight Gain together with Inhibition of Fat Deposition and of Primary Amine Oxidase Activity in Adipose Tissue.

Item
http://www.wikidata.org/entity/Q34572256
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Oral Administration of Semicar ...... se Activity in Adipose Tissue.
@ast
Oral Administration of Semicar ...... se Activity in Adipose Tissue.
@en
Oral Administration of Semicar ...... se Activity in Adipose Tissue.
@nl
type
label
Oral Administration of Semicar ...... se Activity in Adipose Tissue.
@ast
Oral Administration of Semicar ...... se Activity in Adipose Tissue.
@en
Oral Administration of Semicar ...... se Activity in Adipose Tissue.
@nl
prefLabel
Oral Administration of Semicar ...... se Activity in Adipose Tissue.
@ast
Oral Administration of Semicar ...... se Activity in Adipose Tissue.
@en
Oral Administration of Semicar ...... se Activity in Adipose Tissue.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Oral Administration of Semicar ...... se Activity in Adipose Tissue.
@en
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P921
P932